FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip 
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies 
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group 
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties 
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026 
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss 
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions 
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling 
Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project 
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program 
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year 
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland 
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays 
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study 
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector 
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants 
Dublin, Oct. 20, 2016 -- Research and Markets has announced the addition of the "The Overview of Japanese Pharmaceutical Industry ver2016" report to their offering.
This report talks about the overview of Japanese pharmaceutical industry. By reading this report, readers will understand overall picture about the industry, from various aspects.
Domestic pharmaceutical market size is said to be about 6.9 trillion yen at the ex-manufacturer level, and about 10.8 trillion yen in terms of drug price. While the market size of non-prescription drugs is slightly declining, that of ethical drugs is on the rise, accounting for about 90% of the whole market.
Key Topics Covered:
1. Summary
2. Definition of pharmaceutical industry
3. Classification of pharmaceutical industry
4. Definition of drugs
5. Distribution structure of drugs
6. Pharmaceutical market size in Japan
7. Regulation of related laws
8. Related industry groups
9. High profitability
10. Long history and family management
11. Difficulty of new drug development
12. Structural risk peculiar to the pharmaceutical industry, Patent cliff
13. Disclosure of pipeline
14. Low penetration of vertical integration
15. Changing business environment
16. Companies striving for structural reform
17. Differences between Japanese and foreign companies
18. Characteristics of Labour market
19. Concentration of major companies in member countries of the Organization for Economic Co-operation and Development (OECD)
20. Reference: Comparison with the U.S. and European countries
For more information about this report visit http://www.researchandmarkets.com/research/k4qjk2/the_overview_of
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Pharmaceuticals
